Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yunnan Baiyao Plaster is a topical Traditional Chinese Medicine (TCM) formulation used for the relief of pain and inflammation associated with musculoskeletal conditions. The proprietary formula, developed by the Yunnan Baiyao Group, is traditionally used to promote blood circulation, disperse blood stasis, and alleviate pain. In clinical settings, it is being evaluated as an adjunctive therapy for joint pain in patients with active rheumatoid arthritis who are on stable conventional synthetic disease-modifying antirheumatic drug (csDMARD) therapy. The plaster delivers its active herbal constituents transdermally to the affected joints to provide localized analgesic and anti-inflammatory effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yunnan Baiyao Plaster.